Early Health Technology Assessment (HTA) of Olpasiran and Pelacarsen for Secondary Prevention of Coronary Heart Disease (CHD)
Elena Filipova,1,* Ivona Danova,1,* Iana Simova,2– 5,* Toni Vekov2,3,* 1Science Department, Tchaikapharma High Quality Medicines Ltd., Sofia, Bulgaria; 2Cardiology Department, Heart and Brain Center of Excellence, Pleven, Bulgaria; 3Bulgarian Cardiac Institute, Sofia,...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2026-04-01
|
| シリーズ: | ClinicoEconomics and Outcomes Research |
| 主題: | |
| オンライン･アクセス: | https://www.dovepress.com/early-health-technology-assessment-hta-of-olpasiran-and-pelacarsen-for-peer-reviewed-fulltext-article-CEOR |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|